Yudao Shen
Icahn School of Medicine at Mount Sinai
H-index: 20
North America-United States
Top articles of Yudao Shen
Sox11 inhibitors for treating mantle cell lymphoma
2023/8/3
Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader
Oncogene
2023/3/24
Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells
Journal of medicinal chemistry
2022/10/5
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
Nature chemical biology
2022/8
Targeting triple-negative breast cancer by a novel proteolysis targeting chimera degrader of enhancer of zeste homolog 2
ACS Pharmacology & Translational Science
2022/6/24
Abstract LB195: AKT degradation selectively inhibits the growth of PI3K/PTEN pathway mutant cancers with wild type KRAS and BRAF by destabilizing Aurora kinase B
Cancer Research
2022/6/15
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Oncogene
2022/6/10
Exploring degradation of mutant and wild-type epidermal growth factor receptors induced by proteolysis-targeting chimeras
Journal of medicinal chemistry
2022/6/8
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis
Nature cell biology
2022/3
Discovery of potent, selective, and in vivo efficacious AKT kinase protein degraders via structure–activity relationship studies
Journal of medicinal chemistry
2022/2/4
AKT degradation selectively inhibits the growth of PI3K/PTEN pathway–mutant cancers with wild-type KRAS and BRAF by destabilizing aurora kinase B
Cancer discovery
2021/12/1
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models
Science translational medicine
2021/9/29
Harnessing the E3 ligase KEAP1 for targeted protein degradation
Journal of the American Chemical Society
2021/9/14
Methylation of dual-specificity phosphatase 4 controls cell differentiation
Cell reports
2021/7/27
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
Cell
2021/7/22
Cancer selective target degradation by folate-caged PROTACs
Journal of the American Chemical Society
2021/5/10
A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6
Journal of medicinal chemistry
2021/2/16
Design, synthesis, and evaluation of potent, selective, and bioavailable AKT kinase degraders
Journal of medicinal chemistry
2021/12/2
Discovery of First-in-class Protein Arginine Methyltransferase 5 (PRMT5) Degraders
Journal of medicinal chemistry
2020/8/11
Discovery of a First-in-class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor
Journal of medicinal chemistry
2020/5/5